ĀÜĄņĀŅĀ×

The Research and Development Team at Cybrexa Therapeutics is responsible for the discovery, design, and optimization of innovative small molecule DNA repair inhibitors. Comprising experts in chemistry and biology, this interdisciplinary team works collaboratively to advance the company's tumor-localizing peptide technology, aiming to enhance drug efficacy and safety in cancer treatment. Their efforts are critical in identifying and developing novel therapeutics that can be effectively combined with existing chemotherapy and radiotherapy options.